Differential expression of NF-B target genes in MALT lymphoma with and without chromosome translocation: Insights into molecular mechanism

Leukemia

Volumn 24, Issue 8, 2010, Pages 1487-1497

  Hamoudi, R A ^a   Appert, A ^a   Ye, H ^a   Ruskone Fourmestraux, A ^b,c   Streubel, B ^d   Chott, A ^d   Raderer, M ^d   Gong, L ^a   Wlodarska, I ^e   De Wolf Peeters, C ^e   MacLennan, K A ^f   De Leval, L ^g   Isaacson, P G ^h   Du, M Q ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c GELD (Groupe d'Etude des Lymphomes Digestifs)   (France)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^g CHU SART TILMAN   (Belgium)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

chromosome translocation; gene expression profiling; MALT lymphoma; NF B activation

Indexed keywords

CD28 ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 10; PROTEIN BCL 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ARTICLE; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 77955716864     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.118     Document Type: Article

References (39)

1. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4: 644-653.
2. Ye H, Liu H, Attygalle A, Wotherspoon AC, Nicholson AG, Charlotte F et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 2003; 102: 1012-1018.
3. Ye H, Gong L, Liu H, Hamoudi RA, Shirali S, Ho L et al. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J Pathol 2005; 205: 293-301.
4. Streubel B, Simonitsch-Klupp I, Mullauer L, Lamprecht A, Huber D, Siebert R et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004; 18: 1722-1726.
5. Goatly A, Bacon CM, Nakamura S, Ye H, Kim I, Brown PJ et al. FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control. Mod Pathol 2008; 21: 902-911.
6. Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 2001; 276: 19012-19019.
7. Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M et al. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 2004; 427: 167-171.
8. Lucas PC, Kuffa P, Gu S, Kohrt D, Kim DS, Siu K et al. A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment. Oncogene 2007; 26: 5643-5654.
9. Baens M, Fevery S, Sagaert X, Noels H, Hagens S, Broeckx V et al. Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination. Cancer Res 2006; 66: 5270-5277.
10. Li Z, Wang H, Xue L, Shin DM, Roopenian D, Xu W et al. Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma. Blood 2009; 114: 4158-4168.
11. Zhou Y, Ye H, Martin-Subero JI, Hamoudi R, Lu YJ, Wang R et al. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21). Br J Haematol 2006; 133: 35-42.
12. Sagaert X, Theys T, Wolf-Peeters C, Marynen P, Baens M. Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation. Haematologica 2006; 91: 1693-1696.
13. Ho L, Davis RE, Conne B, Chappuis R, Berczy M, Mhawech P et al. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood 2005; 105: 2891-2899.
14. Liu H, Ye H, Ruskone-Fourmestraux A, de Jong D, Pileri S, Thiede C et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H pylori eradication. Gastroenterology 2002; 122: 1286-1294.
15. Ye H, Gong L, Liu H, Ruskone-Fourmestraux A, de Jong D, Pileri S et al. Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication. Gut 2006; 55: 137-138.
16. Okabe M, Inagaki H, Ohshima K, Yoshino T, Li C, Eimoto T et al. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol 2003; 162: 1113-1122.
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
18. Saxena V, Orgill D, Kohane I. Absolute enrichment: gene set enrichment analysis for homeostatic systems. Nucleic Acids Res 2006; 34: e151.
19. Ortutay C, Vihinen M. Immunome: a reference set of genes and proteins for systems biology of the human immune system. Cell Immunol 2006; 244: 87-89.
20. Pepper SD, Saunders EK, Edwards LE, Wilson CL, Miller CJ. The utility of MAS5 expression summary and detection call algorithms. BMC Bioinformatics 2007; 8: 273.
21. Gomariz RP, Arranz A, Juarranz Y, Gutierrez-Canas I, Garcia-Gomez M, Leceta J et al. Regulation of TLR expression, a new perspective for the role of VIP in immunity. Peptides 2007; 28: 1825-1832.
22. Chng WJ, Remstein ED, Fonseca R, Bergsagel PL, Vrana JA, Kurtin PJ et al. Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications. Blood 2009; 113: 635-645.
23. Rubtsov AV, Swanson CL, Troy S, Strauch P, Pelanda R, Torres RM. TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. J Immunol 2008; 180: 3882-3888.
24. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
25. Ohmae T, Hirata Y, Maeda S, Shibata W, Yanai A, Ogura K et al. Helicobacter pylori activates NF-kappaB via the alternative pathway in B lymphocytes. J Immunol 2005; 175: 7162-7169.
26. Yokota S, Ohnishi T, Muroi M, Tanamoto K, Fujii N, Amano K. Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex. FEMS Immunol Med Microbiol 2007; 51: 140-148.
27. Sancho D, Gomez M, Sanchez-Madrid F. CD69 is an immuno-regulatory molecule induced following activation. Trends Immunol 2005; 26: 136-140.
28. Erlanson M, Gronlund E, Lofvenberg E, Roos G, Lindh J. Expression of activation markers CD23 and CD69 in B-cell non-Hodgkin's lymphoma. Eur J Haematol 1998; 60: 125-132.
29. de Jong D, Koster A, Hagenbeek A, Raemaekers J, Veldhuizen D, Heisterkamp S et al. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica 2009; 94: 70-77.
30. Hopken UE, Wengner AM, Loddenkemper C, Stein H, Heimesaat MM, Rehm A et al. CCR7 deficiency causes ectopic lymphoid neogenesis and disturbed mucosal tissue integrity. Blood 2007; 109: 886-895.
31. Nie Y, Waite J, Brewer F, Sunshine MJ, Littman DR, Zou YR. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J Exp Med 2004; 200: 1145-1156.
32. Springael JY, Urizar E, Parmentier M. Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev 2005; 16: 611-623.
33. Lopez-Giral S, Quintana NE, Cabrerizo M, Alfonso-Perez M, Sala-Valdes M, De Soria VG et al. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol 2004; 76: 462-471.
34. Hopken UE, Foss HD, Meyer D, Hinz M, Leder K, Stein H et al. Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood 2002; 99: 1109-1116.
35. Trentin L, Cabrelle A, Facco M, Carollo D, Miorin M, Tosoni A et al. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004; 104: 502-508.
36. Novak A, Akasaka T, Manske M, Gupta M, Witzig T, Dyer MJS et al. Elevated expression of GPR34 and its association with a novel translocation t(X;14)(p11;q32) involving IGHS and GPR34 in MALT lymphoma. Blood 2008; 112: 785, Abstract 2251.
37. Du MQ, Atherton JC. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut 2006; 55: 886-893.
38. McNamara D, El Omar E. Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions. Dig Liver Dis 2008; 40: 504-509.
39. de Jong D, Vyth-Dreese F, Dellemijn T, Verra N, Ruskone-Fourmestraux A, Lavergne-Slove A et al. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma. J Pathol 2001; 193: 318-324.